| Autor: |
Chybicka A; Kliniki Hematologii i Chorób Rozrostowych Dzieci Akademii Medycznej we Wrocławiu., Bogusławska-Jaworska J, Rosińska B, Wecławek-Tompol J, Armata J, Balcerska A, Balwierz W, Bubała H, Drabko K, Eliasińska A, Kedziora M, Sońta-Jakimczyk D, Sopyło B, Kołecki P, Kowalczyk J, Matysiak M, Rokicka-Milewska R, Stefaniak MJ, Stańczak E, Stencel D, Wysocki M, Płoszyńska A |
| Jazyk: |
polština |
| Zdroj: |
Wiadomosci lekarskie (Warsaw, Poland : 1960) [Wiad Lek] 1998; Vol. 51 Suppl 4, pp. 72-8. |
| Abstrakt: |
Total number of 252 cycles of GM-CSF-Leucomax Sandoz (5 mg/kg/day s.c.) and/or G-CSF Filgrastim Hoffmann-La Roche (5-10 mg/kg/day s.c.) was applied in 124 children aged from 0.5-20 years during neutropenia associated with chemotherapy of non-Hodgkin's lymphoma (NHL). Twenty four children with NHL treated according to the same chemotherapy protocol but without G-CSF and GM-CSF served as a control group. Our study have demonstrated the good efficacy of both G-CSF and GM-CSF therapy. They shortened the period of neutropenia, reduced the number of febrile days, infection's duration and decreased the frequency of infectious complications. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
